5061-22-3 nafiverine
상품명칭 |
nafiverine |
영문 이름 |
nafiverine;Nafiverine [INN]; Nafiverine; 2,2'-(1,4-Piperazindiyl)diethylbis(alpha-methyl-1-naphthalinacetat); DA 914; N,N'-Bis(2-(alpha-(1-naphthyl)propionyloxy)ethyl)piperazin; Nafiverina; Nafiverina [INN-Spanish]; Nafiverinum; Nafiverinum [INN-Latin]; UNII-WLT400RC9Q; 1,4-Piperazinediethanol alpha-methyl-1-naphthaleneacetate ester; piperazine-1,4-diyldiethane-2,1-diyl bis[2-(naphthalen-1-yl)propanoate] |
분자식 |
C34H38N2O4 |
분자량 |
538.6765 |
InChI |
InChI=1/C34H38N2O4/c1-25(29-15-7-11-27-9-3-5-13-31(27)29)33(37)39-23-21-35-17-19-36(20-18-35)22-24-40-34(38)26(2)30-16-8-12-28-10-4-6-14-32(28)30/h3-16,25-26H,17-24H2,1-2H3 |
cas번호 |
5061-22-3 |
EC번호 |
225-766-5 |
분자 구조 |
|
밀도 |
1.168g/cm3 |
비등점 |
670.9°C at 760 mmHg |
굴절 지수 |
1.612 |
인화점 |
359.5°C |
증기압 |
7.36E-18mmHg at 25°C |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|